Results 111 to 120 of about 7,822,595 (348)
TRPM8 levels determine tumor vulnerability to channel agonists
Molecular Oncology, EarlyView.TRPM8 is a Ca2+ permissive channel. Regardless of the amount of its transcript, high levels of TRPM8 protein mark different tumors, including prostate, breast, colorectal, and lung carcinomas. Targeting TRPM8 with channel agonists stimulates inward calcium currents followed by emptying of cytosolic Ca2+ stores in cancer cells.
Alessandro Alaimo +18 more
wiley +1 more source
Molecular Oncology, EarlyView.Non‐thermal plasma treatment of melanoma cells induced epithelial‐mesenchymal transition (EMT) in a dose‐dependent fashion. This report highlights the critical need to further investigate potential adverse effects of non‐thermal plasma for cancer therapy and to optimize treatment parameters for clinical translation. Despite the promising results of non‐
Eline Biscop +10 more
wiley +1 more source
ELECTRONIC DOCUMENT AS A SUBJECT OF CRIMINAL LAW PROTECTION
, 2022 S.A. Styazhkina
openalex +2 more sources
A nucleotide‐independent, pan‐RAS‐targeted DARPin elicits anti‐tumor activity in a multimodal manner
Molecular Oncology, EarlyView.We report a Designed Ankyrin Repeat Protein that binds and inhibits RAS proteins, which serve as central cell signaling hubs and are essential for the progression of many cancers. Its unique feature is that it does not discriminate between different RAS isoforms or mutations and is capable of binding to RAS in both its active (GTP‐bound) and inactive ...
Jonas N. Kapp +13 more
wiley +1 more source
Some core concepts of domain analysis
Em QuestãoThis article claims that information systems should provide reliable and trustworthy information, and that this demand imply a re-orientation of information science with knowledge organization from, for example, approaches based on ...
Birger Hjørland
doaj +1 more source
An Objective or Subjective Approach to Rectification of Documents in Scotland? [PDF]
Edinburgh Law Review, 2021 openaire +3 more sources
Molecular Oncology, EarlyView.C–C chemokine receptor type 9 (CCR9) is an immune checkpoint in pancreatic ductal adenocarcinoma (PDAC). Novel anti‐CCR9 antibody SRB2 was evaluated in combination with cytotoxic chemotherapy in PDAC cells, patient‐derived organoids, patient‐derived xenografts, and humanized mouse models.
Hannah G. McDonald +18 more
wiley +1 more source
Iranian Journal of Information Processing & Management, 2014 In this study, the relevance amount of documents has been investigated by using google cross-language retrieval tools about a agriculture subject area in cross-language retrieval form, are retrieved.
Fatemeh Jamshidi Ghahfarokhi
doaj